Integrating Data on Macrovascular and Microvascular Outcomes in Diabetes: Evolving Treatment Strategies
WebcastFaculty
OVERVIEW
Integrating Data on Macrovascular and Microvascular Outcomes in Diabetes: Evolving Treatment Strategies is organized by National Association for Continuing Education (NACE) and will be held during Oct 12, 2017 - Oct 11, 2018.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This activity utilizes segments of a presentation by the faculty recorded at one of the Emerging Challenges in Primary Care symposia, to reinforce teaching points made during this program. Participants can expect to learn how to effectively integrate the SLGT2 class of medications into practice and the emerging data surrounding renal and macrovascular effects of diabetes treatments.
Conference Objectives are:
• Describe the role of the kidney in glucose metabolism in health and disease.
• Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations.
• Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options.
• Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This activity utilizes segments of a presentation by the faculty recorded at one of the Emerging Challenges in Primary Care symposia, to reinforce teaching points made during this program. Participants can expect to learn how to effectively integrate the SLGT2 class of medications into practice and the emerging data surrounding renal and macrovascular effects of diabetes treatments.
Conference Objectives are:
• Describe the role of the kidney in glucose metabolism in health and disease.
• Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations.
• Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options.
• Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.
Additional details will be posted as soon as they are available.
SPECIALITIES
Endocrinology, Metabolism and Diabetes
Quick Links